SCHEMBL10073622

SCHEMBL10073622

Cc1cc(Nc2cc(I)nc(S)n2)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91111 0.83 GSK3B (0.35) —
SCHEMBL13060369 0.79 MEN1 (0.37) —
SCHEMBL19796066 0.71 MAPT (0.41) —
SCHEMBL30702750 0.70 PAK4 (0.38) —
SCHEMBL14026511 0.70 PAK4 (0.38) —
SCHEMBL91092 0.69 — —
SCHEMBL13060371 0.68 JAK2 (0.31) —
SCHEMBL14026508 0.67 PDE2A (0.38) —
SCHEMBL23011369 0.66 — —
SCHEMBL61333 0.66 KMT2A (0.53) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142660-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-07 — — US disclosed
Send feedback